Components of TDDS Overview
20 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

The polymer matrix in transdermal drug delivery systems is not responsible for controlling the release of the drug.

False

Natural polymers used in TDDS include cellulose derivatives and synthetic elastomers.

False

Permeation enhancers are designed to decrease the permeability of the stratum corneum to improve drug absorption.

False

Chemical compatibility is not a requirement for polymers in transdermal drug delivery systems.

<p>False</p> Signup and view all the answers

Ethanol and propylene glycol are examples of alcohols and polyols used as permeation enhancers.

<p>True</p> Signup and view all the answers

Polyvinyl alcohol is an example of a natural polymer used in transdermal drug delivery systems.

<p>False</p> Signup and view all the answers

A permeation enhancer must be pharmacologically inert, nontoxic, and compatible with most drugs.

<p>True</p> Signup and view all the answers

Synthetic polymers such as polyisobutylene are used in transdermal drug delivery systems.

<p>True</p> Signup and view all the answers

The primary purpose of a backing laminate in a transdermal patch is to allow drug passage.

<p>False</p> Signup and view all the answers

Natural rubber is a synthetic elastomer used in the formulation of TDDS.

<p>False</p> Signup and view all the answers

Permeation enhancers can disrupt the organization of intercellular lipids and increase their _____.

<p>True</p> Signup and view all the answers

The term 'binary systems' in permeation enhancers refers exclusively to sodium lauryl sulfate.

<p>False</p> Signup and view all the answers

PSA materials should be removable without leaving any remains on the skin surface.

<p>True</p> Signup and view all the answers

Vinyl, polyethylene, and polyester films are not examples of backing laminates used in transdermal delivery systems.

<p>False</p> Signup and view all the answers

Chemical resistance is a minor concern when designing a backing layer for transdermal systems.

<p>False</p> Signup and view all the answers

Release liners are considered part of the dosage form for delivering the drug.

<p>False</p> Signup and view all the answers

Extraction of lipids from the stratum corneum is one of the mechanisms by which permeation enhancers operate.

<p>True</p> Signup and view all the answers

Polyacrylates, polyisobutylene, and silicon-based adhesives are examples of materials used for transdermal drug delivery systems.

<p>True</p> Signup and view all the answers

The release coating layer of a release liner is typically composed of polyurethane or rubber.

<p>False</p> Signup and view all the answers

Non-ionic surfactants are a category of permeation enhancers that includes ingredients like sodium deoxycholate.

<p>False</p> Signup and view all the answers

Study Notes

Components of TDDS

  • Transdermal drug delivery systems (TDDS) components include:
    • Polymer matrix/drug reservoir
    • Drug
    • Permeation enhancers
    • Pressure-sensitive adhesive (PSA)
    • Backing laminates
    • Release liner
    • Other excipients

Polymer Matrix

  • Polymers are the backbone of TDDS, controlling drug release.
  • Polymer matrix can be prepared by dispersing the drug in a liquid or solid synthetic polymer base.
  • TDDS polymers need biocompatibility and chemical compatibility with the drug and other components, like penetration enhancers.
  • They must provide consistent and effective drug delivery throughout the product's shelf life and be safe.
  • Examples of natural polymers include cellulose derivatives, zein, gelatin, shellac, waxes, gums, natural rubber, and chitosan.
  • Synthetic elastomers include polybutadiene, hydrin rubber, polyisobutylene, silicon rubber, nitrile, acrylonitrile, neoprene, and butyl rubber.
  • Synthetic polymers include polyvinyl alcohol, polyvinyl chloride, polyethylene, polypropylene, polyacrylate, polyamide, polyurea, polymethylmethacrylate, and polyvinylpyrrolidone.

Drug

  • Drugs used in TDDS require a suitable mix of physicochemical and biological properties for effective transdermal delivery.
  • Commonly used drugs are candidates for passive adhesive transdermal patches.

Permeation Enhancers

  • These chemical compounds increase stratum corneum permeability, increasing drug concentration to higher therapeutic levels.
  • Permeation enhancers interact with stratum corneum components, including proteins and lipids.
  • They alter protein and lipid packaging, modifying the barrier functions to enhance permeability.
  • Permeation enhancers should be pharmacologically inert, non-toxic, non-irritating, non-allergenic, odorless, tasteless, colorless, compatible with most excipients, inexpensive, and have good solvent properties.
  • Examples of permeation enhancer classes include alcohols and polyols, surfactants, fatty acids, amines and amides, terpenes, and sulfoxides.

Mechanism of Permeation

  • Permeation enhancers can increase skin permeability via mechanisms like interaction with intercellular lipids, disruption of lipid organization, extracting lipids from the stratum corneum, and displacing bound water.
  • Extracting lipids, or release/reduction of lipid organization, in the stratum corneum increases permeability.

Classification of Permeation Enhancers

  • Solvents (e.g., ethanol, propylene glycol)
  • Surfactants (e.g., Tween, Span, SLS)
  • Fatty acids (e.g., oleic acid)
  • Amines and amides (e.g., N-methyl pyrrolidone)
  • Terpenes (e.g., limonene)
  • Sulfoxides (e.g., dimethyl sulfoxide)

Pressure-sensitive adhesive (PSA)

  • PSAs maintain contact between the transdermal system and the skin surface.
  • They adhere firmly with moderate pressure but are removable without leaving residue.
  • Common materials include polyacrylates, polyisobutylene, and silicon-based adhesives.

Backing Laminates

  • Chemical resistance is a key consideration when designing backing layers.
  • Compatibility of backing layers with excipients, drugs, and penetration enhancers is important to prevent leaching and diffusion.
  • Backing laminates provide a protective layer and keep the drug reservoir from the atmosphere.
  • Examples include vinyl, polyethylene film, and polyester films.

Release Liner

  • The release liner is a protective layer applied during storage, then removed prior to patch application.
  • It's considered a primary packaging component, not part of the dosage form.
  • It must be chemically inert and have suitable permeation characteristics for the drug and enhancers.
  • Materials like paper, fabric, polyethylene, polyvinyl chloride, and silicon are frequently used.

Other Excipients

  • Solvents such as chloroform, methanol, acetone, isopropanol, and dichloromethane are used in preparing the drug reservoir.
  • The protective liner is removed before patch application.
  • Thus, it's part of primary packaging, not the dosage form.

Transdermal Patch Designs

  • Common designs involve a drug-containing matrix, reservoir, and multilaminate structures, as well as backing material and adhesive layers.
  • There are different designs, including reservoir and matrix patches, and their components.

Evaluation Methods

  • Physico-chemical evaluation: Includes interaction studies, thickness assessment, weight uniformity, folding, moisture content, water vapor permeability, flatness tests, break tests, and drug/content uniformity tests.
  • In vitro evaluation: Includes in vitro release studies and in vitro skin permeation studies.
  • In vivo evaluation: Involves animal and human studies, including skin irritation tests.
  • Stability studies assess product stability during storage and use.

Evaluation of Adhesives

  • Testing methods for adhesives include peel adhesion, thumb crack, rolling ball, quick test, probe tack, and shear strength properties.

Application of TDDS

  • TDDS are used for various purposes, such as for hypertensive medication, pain relief, delivering vitamin B12, antidepressants, easy breathing patches, hormone therapy, and nicotine patches.

Future Scope

  • Potential future applications include insulin patches, patches for cancer pain, smoking cessation, depression treatment, and neurological disorders and conditions.
  • The development of iontophoretic patches for diseases such as tennis elbow and migraine headaches and Transdermal glyceryl trinitrate for acute stroke.

Conclusion

  • TDDS are useful for topical drug delivery.
  • Unstable drugs in the gastrointestinal tract are suitable candidates for TDDS.
  • Transdermal route is becoming increasingly accepted for drug administration due to advances in technology.
  • Many new drugs are being developed and incorporated into TDDS, making it a potentially significant and widely-used drug delivery system.

Studying That Suits You

Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

Quiz Team

Related Documents

Industrial Pharmacy Lecture Notes PDF

Description

This quiz explores the various components of Transdermal Drug Delivery Systems (TDDS), focusing on the role of the polymer matrix and its importance in drug release. It covers different types of polymers, including natural and synthetic, and their compatibility with drugs. Test your knowledge on the essential elements that make TDDS effective.

More Like This

Use Quizgecko on...
Browser
Open
Browser
Browser